Lobeck H - Search Results

1

Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease.

Mueller AR, Platz KP, Bechstein WO, Blumhardt G, Lobeck H, Hop U, Neuhaus P. Mueller AR, et al. Among authors: lobeck h. Transplant Proc. 1994 Dec;26(6):3637-9. Transplant Proc. 1994. PMID: 7527984 No abstract available.

2

Hepatitis C virus reinfection in allografts after orthotopic liver transplantation.

König V, Bauditz J, Lobeck H, Lüsebrink R, Neuhaus P, Blumhardt G, Bechstein WO, Neuhaus R, Steffen R, Hopf U. König V, et al. Among authors: lobeck h. Hepatology. 1992 Nov;16(5):1137-43. doi: 10.1002/hep.1840160506. Hepatology. 1992. PMID: 1330865

3

Experience with immunoprophylaxis and interferon therapy after liver transplantation in HBsAG positive patients.

Neuhaus P, Steffen R, Blumhardt G, Bechstein W, Keck H, Lemmens HP, Neuhaus R, Lobeck H, König V, Hopf U. Neuhaus P, et al. Among authors: lobeck h. Transplant Proc. 1991 Feb;23(1 Pt 2):1522-4. Transplant Proc. 1991. PMID: 1671180 No abstract available.

4

[Hepatitis B in established cardiac cirrhosis--a rare indication for liver transplantation].

Bechstein WO, Blumhardt G, Neuhaus P, Hopf U, Lobeck H. Bechstein WO, et al. Among authors: lobeck h. Leber Magen Darm. 1989 Dec;19(6):327-31. Leber Magen Darm. 1989. PMID: 2615553 German.

5

OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection.

Platz KP, Mueller AR, Zytowski M, Bechstein WO, Blumhardt G, Lobeck H, Neuhaus P. Platz KP, et al. Among authors: lobeck h. Transplant Proc. 1995 Feb;27(1):1111-3. Transplant Proc. 1995. PMID: 7533357 Clinical Trial. No abstract available.

6

The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A.

Mueller AR, Platz KP, Blumhardt G, Bechstein WO, Steinmüller T, Christe W, Hopf U, Lobeck H, Neuhaus P. Mueller AR, et al. Among authors: lobeck h. Transplant Proc. 1995 Feb;27(1):1117-20. Transplant Proc. 1995. PMID: 7533359 Clinical Trial. No abstract available.

7

Analysis of risk factors for recurrence of hepatocellular carcinoma after orthotopic liver transplantation.

Lohmann R, Bechstein WO, Langrehr JM, Knoop M, Lobeck H, Keck H, Lemmems HP, Blumhardt G, Neuhaus P. Lohmann R, et al. Among authors: lobeck h. Transplant Proc. 1995 Feb;27(1):1245-6. Transplant Proc. 1995. PMID: 7533376 Clinical Trial. No abstract available.

8

Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.

Platz KP, Mueller AR, Jonas S, Blumhardt G, Bechstein WO, Lobeck H, Neuhaus HL. Platz KP, et al. Among authors: lobeck h. Clin Transplant. 1995 Jun;9(3 Pt 1):146-54. Clin Transplant. 1995. PMID: 7549052 Clinical Trial.

9

The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?

Mueller AR, Platz KP, Blumhardt G, Bechstein WO, Steinmüller T, Christe W, Hopf U, Lobeck H, Neuhaus P. Mueller AR, et al. Among authors: lobeck h. Clin Transplant. 1995 Jun;9(3 Pt 1):176-84. Clin Transplant. 1995. PMID: 7549057 Clinical Trial.

10

Interleukin-2 receptor antibody vs ATG for induction immunosuppression after liver transplantation: initial results of a prospective randomized trial.

Lemmens HP, Langrehr JM, Bechstein WO, Blumhardt G, Keck H, Lüsebrink R, Knoop M, Lohmann R, Tullius S, Lobeck H, et al. Lemmens HP, et al. Among authors: lobeck h. Transplant Proc. 1995 Feb;27(1):1140-1. Transplant Proc. 1995. PMID: 7878826 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters